Skip Nav Destination
Issues
1 November 2001
ISSN 1078-0432
EISSN 1557-3265
Issue Sections
Editorial
Minireview
The Biology Behind
Advances in Brief
Molecular Oncology, Markers, Clinical Correlates
Experimental Therapeutics, Preclinical Pharmacology
Regular Articles
Clinical Trials
Phase II Trial of Cisplatin, Interferon α-2b, Doxorubicin, and 5-Fluorouracil for Biliary Tract Cancer1
Yehuda Z. Patt; Manal M. Hassan; Richard D. Lozano; Kimberly A. Waugh; Ashraful M. Hoque; Adam I. Frome; Sandeep Lahoti; Lee Ellis; J. Nicolas Vauthey; Steven A. Curley; Isac I. Schnirer; Isaac Raijman
Cancer Biology, Immunology, Cytokines
Research Articles
Molecular Oncology, Markers, Clinical Correlates
Hypoxia-regulated Carbonic Anhydrase-9 (CA9) Relates to Poor Vascularization and Resistance of Squamous Cell Head and Neck Cancer to Chemoradiotherapy
Michael I. Koukourakis; Alexandra Giatromanolaki; Efthimios Sivridis; Konstantinos Simopoulos; Jaromir Pastorek; Charles C. Wykoff; Kevin C. Gatter; Adrian L. Harris
Chromosome 6 Abnormalities in Ovarian Surface Epithelial Tumors of Borderline Malignancy Suggest a Genetic Continuum in the Progression Model of Ovarian Neoplasms1
Maria Grazia Tibiletti; Barbara Bernasconi; Daniela Furlan; Paola Bressan; Roberta Cerutti; Carla Facco; Massimo Franchi; Cristina Riva; Raffaella Cinquetti; Carlo Capella; Roberto Taramelli
Single Nucleotide Polymorphisms in the Human Reduced Folate Carrier: Characterization of a High-Frequency G/A Variant at Position 80 and Transport Properties of the His27 and Arg27 Carriers1
Johnathan R. Whetstine; Andrew J. Gifford; Teah Witt; Xiang Y. Liu; Robin M. Flatley; Murray Norris; Michelle Haber; Jeffrey W. Taub; Y. Ravindranath; Larry H. Matherly
Inverse Correlation of Thioredoxin Expression with Estrogen Receptor- and p53-dependent Tumor Growth in Breast Cancer Tissues1
Yasuo Matsutani; Akira Yamauchi; Rei Takahashi; Masaya Ueno; Kiyotugu Yoshikawa; Kazuo Honda; Hajime Nakamura; Hironori Kato; Hiroshi Kodama; Takashi Inamoto; Junji Yodoi; Yoshio Yamaoka
Expression Levels of the Nerve Growth Factor Receptors TrkA and p75 in Effusions and Solid Tumors of Serous Ovarian Carcinoma Patients1
Ben Davidson; Philip Lazarovici; Alexandra Ezersky; Jahn M. Nesland; Aasmund Berner; Bjørn Risberg; Claes G. Tropé; Gunnar B. Kristensen; Mariusz Goscinski; Gregg van de Putte; Reuven Reich
Experimental Therapeutics, Preclinical Pharmacology
Preclinical Antitumor Activity and Pharmacodynamic Studies with the Farnesyl Protein Transferase Inhibitor R115777 in Human Breast Cancer
Lloyd R. Kelland; Vicki Smith; Melanie Valenti; Lisa Patterson; Paul A. Clarke; Simone Detre; Dave End; Angela J. Howes; Mitch Dowsett; Paul Workman; Stephen R. D. Johnston
Advertisement
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.